MITOCHONDRIAL ENCEPHALOPATHY (MELAS)

Clinical trials for MITOCHONDRIAL ENCEPHALOPATHY (MELAS) explained in plain language.

Never miss a new study

Get alerted when new MITOCHONDRIAL ENCEPHALOPATHY (MELAS) trials appear

Sign up with your email to follow new studies for MITOCHONDRIAL ENCEPHALOPATHY (MELAS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental drug trial aims to tame devastating seizures in rare genetic disorders

Disease control Terminated

This study tested whether vatiquinone could reduce seizure frequency in people with mitochondrial diseases who have epilepsy that doesn't respond well to standard medications. It involved 68 participants who were randomly assigned to receive either the drug or a placebo for 24 we…

Matched conditions: MITOCHONDRIAL ENCEPHALOPATHY (MELAS)

Phase: PHASE2, PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

MITOCHONDRIAL ENCEPHALOPATHY (MELAS)

Get alerted when new MITOCHONDRIAL ENCEPHALOPATHY (MELAS) trials appear

Experimental drug trial aims to tame devastating seizures in rare genetic disorders